Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.
暂无分享,去创建一个
[1] D. Hricik,et al. Use of Sirolimus in Solid Organ Transplantation , 2012, Drugs.
[2] D. Fingar,et al. mTOR Kinase Domain Phosphorylation Promotes mTORC1 Signaling, Cell Growth, and Cell Cycle Progression , 2011, Molecular and Cellular Biology.
[3] M. Loda,et al. Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis. , 2011, Cancer research.
[4] Susan S. Taylor,et al. Hydrophobic Motif Phosphorylation Is Not Required for Activation Loop Phosphorylation of p70 Ribosomal Protein S6 Kinase 1 (S6K1)* , 2011, The Journal of Biological Chemistry.
[5] L. Cantley,et al. Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. , 2011, Molecular cell.
[6] G. Condorelli,et al. IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation , 2011, Proceedings of the National Academy of Sciences.
[7] D. Sabatini,et al. The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling , 2011, Science.
[8] M. White,et al. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. , 2011, Molecules and Cells.
[9] Adam S. Lazorchak,et al. mTOR Complex 2 Targets Akt for Proteasomal Degradation via Phosphorylation at the Hydrophobic Motif* , 2011, The Journal of Biological Chemistry.
[10] S. Akira,et al. Akt Contributes to Activation of the TRIF-Dependent Signaling Pathways of TLRs by Interacting with TANK-Binding Kinase 1 , 2011, The Journal of Immunology.
[11] Jiahuai Han,et al. Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy depletion-induced suppression of mTORC1 , 2010, Nature Cell Biology.
[12] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[13] S. Gygi,et al. Quantitative Phosphoproteomic Analysis Identifies the Adaptor Protein Grb 10 as an mTORC 1 Substrate that Negatively Regulates Insulin Signaling , 2011 .
[14] T. Fenton,et al. Functions and regulation of the 70kDa ribosomal S6 kinases. , 2011, The international journal of biochemistry & cell biology.
[15] M. Loda,et al. Therapeutics , Targets , and Chemical Biology Differential Expression of S 6 K 2 Dictates Tissue-Specific Requirement for S 6 K 1 in Mediating Aberrant mTORC 1 Signaling and Tumorigenesis , 2011 .
[16] Philippe P Roux,et al. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide , 2010, The EMBO journal.
[17] D. Fingar,et al. ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)* , 2010, The Journal of Biological Chemistry.
[18] D. Fingar,et al. mTORC1 Inhibition via Rapamycin Promotes Triacylglycerol Lipolysis and Release of Free Fatty Acids in 3T3-L1 Adipocytes , 2010, Lipids.
[19] Rudolph L. Leibel,et al. Obesity and leptin resistance: distinguishing cause from effect , 2010, Trends in Endocrinology & Metabolism.
[20] Justin Chapman,et al. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). , 2010, The Biochemical journal.
[21] J. Hershey. Regulation of protein synthesis and the role of eIF3 in cancer. , 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[22] D. Sabatini,et al. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. , 2010, Molecular cell.
[23] D. Klionsky,et al. Eaten alive: a history of macroautophagy , 2010, Nature Cell Biology.
[24] Nektarios Tavernarakis,et al. Can autophagy promote longevity? , 2010, Nature Cell Biology.
[25] D. Meek,et al. S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response , 2010, The EMBO journal.
[26] A. Abizaid,et al. New Drug-Eluting Stents: An Overview on Biodegradable and Polymer-Free Next-Generation Stent Systems , 2010, Circulation. Cardiovascular interventions.
[27] T. Fenton,et al. S6K1 is acetylated at lysine 516 in response to growth factor stimulation. , 2010, Biochemical and biophysical research communications.
[28] Qicheng Ma,et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. , 2010, Molecular cell.
[29] D. Fingar,et al. p70 Ribosomal S6 kinase is required for airway smooth muscle cell size enlargement but not increased contractile protein expression. , 2010, American journal of respiratory cell and molecular biology.
[30] N. Sonenberg,et al. S6K1 plays a critical role in early adipocyte differentiation. , 2010, Developmental cell.
[31] A. Teleman,et al. PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation. , 2010, Cell metabolism.
[32] Hasmik Keshishian,et al. Rictor Phosphorylation on the Thr-1135 Site Does Not Require Mammalian Target of Rapamycin Complex 2 , 2010, Molecular Cancer Research.
[33] Linda Partridge,et al. Extending Healthy Life Span—From Yeast to Humans , 2010, Science.
[34] Chang Hwa Jung,et al. mTOR regulation of autophagy , 2010, FEBS letters.
[35] Daniel J Klionsky,et al. Mammalian autophagy: core molecular machinery and signaling regulation. , 2010, Current opinion in cell biology.
[36] R. Wessely. New drug-eluting stent concepts , 2010, Nature Reviews Cardiology.
[37] D. Sabatini,et al. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.
[38] I. Gout,et al. Involvement of Heterogeneous Ribonucleoprotein F in the Regulation of Cell Proliferation via the Mammalian Target of Rapamycin/S6 Kinase 2 Pathway , 2010, The Journal of Biological Chemistry.
[39] Kathryn G. Foster,et al. Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony* , 2010, The Journal of Biological Chemistry.
[40] J. Backer,et al. The Late Endosome is Essential for mTORC1 Signaling , 2010, Molecular biology of the cell.
[41] J. Downward,et al. Rictor is a novel target of p70 S6 kinase-1 , 2010, Oncogene.
[42] E. Klann,et al. mTOR signaling: At the crossroads of plasticity, memory and disease , 2010, Trends in Neurosciences.
[43] T. Fenton,et al. Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo. , 2010, The international journal of biochemistry & cell biology.
[44] K. Kandror,et al. Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage , 2010, Diabetes.
[45] J. Hershey. Regulation of protein synthesis and the role of eIF 3 in cancer , 2010 .
[46] D. Alessi,et al. The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.
[47] D. Fingar,et al. mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action* , 2009, The Journal of Biological Chemistry.
[48] Philippe P Roux,et al. mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling , 2009, Molecular and Cellular Biology.
[49] Kathryn G. Foster,et al. Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863 and Multisite Phosphorylation* , 2009, The Journal of Biological Chemistry.
[50] Sujata Sharma,et al. Structural Basis of Human p70 Ribosomal S6 Kinase-1 Regulation by Activation Loop Phosphorylation , 2009, The Journal of Biological Chemistry.
[51] Janet M. Thornton,et al. Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span , 2009, Science.
[52] G. Thomas,et al. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. , 2009, American journal of physiology. Renal physiology.
[53] J. Asara,et al. Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 , 2009, Molecular and Cellular Biology.
[54] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[55] Chin-Lee Wu,et al. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. , 2009, Cancer research.
[56] Chin-Lee Wu,et al. Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway , 2009, PloS one.
[57] Marco Pahor,et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.
[58] Kathryn G. Foster,et al. Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth , 2009, Molecular and Cellular Biology.
[59] D. Sabatini,et al. mTOR Mediated Anti-Cancer Drug Discovery. , 2009, Drug discovery today. Therapeutic strategies.
[60] S. Gygi,et al. p90 Ribosomal S6 Kinase and p70 Ribosomal S6 Kinase Link Phosphorylation of the Eukaryotic Chaperonin Containing TCP-1 to Growth Factor, Insulin, and Nutrient Signaling* , 2009, Journal of Biological Chemistry.
[61] T. Sturgill,et al. Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR* , 2009, Journal of Biological Chemistry.
[62] N. Freedman,et al. Mice Deficient in Ribosomal Protein S6 Phosphorylation Suffer from Muscle Weakness that Reflects a Growth Defect and Energy Deficit , 2009, PloS one.
[63] A. Nakashima,et al. Specific Activation of mTORC1 by Rheb G-protein in Vitro Involves Enhanced Recruitment of Its Substrate Protein* , 2009, Journal of Biological Chemistry.
[64] J. Blenis,et al. Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.
[65] D. Sabatini,et al. DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.
[66] D. Alessi,et al. New Insights into mTOR Signaling: mTORC2 and Beyond , 2009, Science Signaling.
[67] D. Guertin,et al. The Pharmacology of mTOR Inhibition , 2009, Science Signaling.
[68] H. Münzberg,et al. Critical role for hypothalamic mTOR activity in energy balance. , 2009, Cell metabolism.
[69] I. Gout,et al. The ubiquitination of ribosomal S6 kinases is independent from the mitogen-induced phosphorylation/activation of the kinase. , 2009, The international journal of biochemistry & cell biology.
[70] M. Holz,et al. S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation* , 2009, Journal of Biological Chemistry.
[71] M. Okada,et al. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK–ERK pathway to late endosomes , 2009, The EMBO journal.
[72] M. Hall,et al. The TSC-mTOR Pathway Mediates Translational Activation of TOP mRNAs by Insulin Largely in a Raptor- or Rictor-Independent Manner , 2009, Molecular and Cellular Biology.
[73] J. Blenis,et al. Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance, and cancer therapy , 2009, Cell cycle.
[74] S. Kimball,et al. ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression. , 2009, Biochemical and biophysical research communications.
[75] Jeffrey P. MacKeigan,et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.
[76] Gopal Singh,et al. Regulation and localization of ribosomal protein S6 kinase 1 isoforms , 2009, Growth factors.
[77] S. Kimball,et al. ATF 4 is Necessary and Sufficient for ER Stress-induced Upregulation of REDD 1 Expression , 2009 .
[78] O. Meyuhas,et al. Chapter 3 Ribosomal Protein S6 Kinase , 2009 .
[79] O. Meyuhas,et al. Ribosomal protein S6 kinase from TOP mRNAs to cell size. , 2009, Progress in molecular biology and translational science.
[80] M. Holz,et al. S6 Kinase 1 Regulates Estrogen Receptor (cid:1) in Control of Breast Cancer Cell Proliferation * , 2009 .
[81] D. A. Foster,et al. Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin , 2008, Molecular and Cellular Biology.
[82] D. Alessi,et al. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). , 2008, The Biochemical journal.
[83] Hiraku Ono,et al. Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. , 2008, Cell metabolism.
[84] Philippe P Roux,et al. Oncogenic MAPK Signaling Stimulates mTORC1 Activity by Promoting RSK-Mediated Raptor Phosphorylation , 2008, Current Biology.
[85] Claudio R. Santos,et al. SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth , 2008, Cell metabolism.
[86] P. Pandolfi,et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. , 2008, The Journal of clinical investigation.
[87] M. Karin,et al. p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling , 2008, Cell.
[88] A. Newton,et al. The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C , 2008, The EMBO journal.
[89] K. Inoki,et al. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling , 2008, The EMBO journal.
[90] T. P. Neufeld,et al. Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.
[91] S. Ceman,et al. S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade* , 2008, Journal of Biological Chemistry.
[92] H. A. Brown,et al. Phospholipase D1 is an effector of Rheb in the mTOR pathway , 2008, Proceedings of the National Academy of Sciences.
[93] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[94] Han C. Dan,et al. Differential Involvement of IκB Kinases α and β in Cytokine- and Insulin-Induced Mammalian Target of Rapamycin Activation Determined by Akt1 , 2008, The Journal of Immunology.
[95] J. Ting,et al. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. , 2008, Genes & development.
[96] B. Manning,et al. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.
[97] T. Fenton,et al. Regulation of ribosomal protein S6 kinases by ubiquitination. , 2008, Biochemical and biophysical research communications.
[98] I. Gout,et al. Ribosomal protein S6 kinase 1 interacts with and is ubiquitinated by ubiquitin ligase ROC1. , 2008, Biochemical and biophysical research communications.
[99] J. Blenis,et al. The RSK factors of activating the Ras/MAPK signaling cascade. , 2008, Frontiers in bioscience : a journal and virtual library.
[100] B. Turk,et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.
[101] J. Blenis,et al. SKAR Links Pre-mRNA Splicing to mTOR/S6K1-Mediated Enhanced Translation Efficiency of Spliced mRNAs , 2008, Cell.
[102] B. Manning,et al. The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2 , 2008, Molecular and Cellular Biology.
[103] E. Jacinto,et al. TOR regulation of AGC kinases in yeast and mammals. , 2008, The Biochemical journal.
[104] D. Sgroi,et al. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. , 2008, Genes & development.
[105] M. Hung,et al. IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. , 2008, International journal of molecular medicine.
[106] O. Meyuhas. Physiological roles of ribosomal protein S6: one of its kind. , 2008, International review of cell and molecular biology.
[107] E. Klann,et al. Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity. , 2008, Learning & memory.
[108] V. Mootha,et al. mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.
[109] N. Sonenberg,et al. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. , 2007, Cancer research.
[110] R. Quintanilla,et al. Regulation of catalytic activity of S6 kinase 2 during cell cycle , 2007, Molecular and Cellular Biochemistry.
[111] Yu Li,et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[112] R. Rossi,et al. Identification of S6K2 as a centrosome‐located kinase , 2007, FEBS letters.
[113] G. Hortobagyi,et al. IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway , 2007, Cell.
[114] A. Nakashima,et al. The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1* , 2007, Journal of Biological Chemistry.
[115] R. Roth,et al. PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.
[116] Mazhar Adli,et al. Regulation of Mammalian Target of Rapamycin Activity in PTEN-Inactive Prostate Cancer Cells by IκB Kinase α , 2007 .
[117] P. Bénit,et al. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. , 2007, Cell metabolism.
[118] G. Thomas,et al. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.
[119] S. Carr,et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.
[120] A. Krainer,et al. The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.
[121] Timothy J. Griffin,et al. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.
[122] D. Guertin,et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.
[123] J. Blenis,et al. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways , 2006, Oncogene.
[124] Michele Pagano,et al. S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.
[125] A. Lipovsky,et al. S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. , 2006, Molecular cell.
[126] J. Qin,et al. SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.
[127] Brian Raught,et al. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity , 2006, The EMBO journal.
[128] George Thomas,et al. Hypothalamic mTOR Signaling Regulates Food Intake , 2006, Science.
[129] D. Sabatini,et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.
[130] Michele Pagano,et al. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. , 2006, Science.
[131] R. Hresko,et al. mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes* , 2005, Journal of Biological Chemistry.
[132] D. Fruman,et al. S6 kinase 2 potentiates interleukin‐3‐driven cell proliferation , 2005, Journal of leukocyte biology.
[133] Steven P. Gygi,et al. mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.
[134] Yuval Dor,et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. , 2005, Genes & development.
[135] J. Blenis,et al. Identification of S6 Kinase 1 as a Novel Mammalian Target of Rapamycin (mTOR)-phosphorylating Kinase* , 2005, Journal of Biological Chemistry.
[136] Robert T. Abraham,et al. Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 Is Mediated by p70S6 Kinase* , 2005, Journal of Biological Chemistry.
[137] J. Diamond. Collapse: How Societies Choose to Fail or Succeed , 2005 .
[138] D. Sabatini,et al. Structure of S6 Kinase 1 Determines whether Raptor-mTOR or Rictor-mTOR Phosphorylates Its Hydrophobic Motif Site*♦ , 2005, Journal of Biological Chemistry.
[139] C. Proud,et al. The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses* , 2005, Journal of Biological Chemistry.
[140] Jian-Kang Chen,et al. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. , 2005, Journal of the American Society of Nephrology : JASN.
[141] Joseph Avruch,et al. Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.
[142] Paul Tempst,et al. Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.
[143] J. Blenis,et al. Characterization of a Conserved C-terminal Motif (RSPRR) in Ribosomal Protein S6 Kinase 1 Required for Its Mammalian Target of Rapamycin-dependent Regulation* , 2005, Journal of Biological Chemistry.
[144] N. Sonenberg,et al. Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.
[145] E. Hafen,et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. , 2004, Genes & development.
[146] G. Thomas,et al. Disruption of the Mouse mTOR Gene Leads to Early Postimplantation Lethality and Prohibits Embryonic Stem Cell Development , 2004, Molecular and Cellular Biology.
[147] R. Loewith,et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.
[148] B. Hemmings,et al. Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase*♦ , 2004, Journal of Biological Chemistry.
[149] J. Auwerx,et al. Corrigendum: Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.
[150] T. Hunter,et al. Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.
[151] Steven P Gygi,et al. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[152] S. Gygi,et al. SKAR Is a Specific Target of S6 Kinase 1 in Cell Growth Control , 2004, Current Biology.
[153] M. Murakami,et al. mTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells , 2004, Molecular and Cellular Biology.
[154] D. Guertin,et al. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.
[155] I. Gout,et al. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.
[156] J. Blenis,et al. Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy , 2004, Molecular and Cellular Biology.
[157] A. Prescott,et al. The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation , 2004, The EMBO journal.
[158] A. Gingras,et al. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases , 2004, The EMBO journal.
[159] Stefano Fumagalli,et al. S6K1−/−/S6K2−/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway , 2004, Molecular and Cellular Biology.
[160] J. Blenis,et al. mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E , 2004, Molecular and Cellular Biology.
[161] J. Blenis,et al. Deletion of Ribosomal S 6 Kinases Does Not Attenuate Pathological , Physiological , or Insulin-Like Growth Factor 1 Receptor – Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy , 2004 .
[162] J. Broach,et al. The role of phosphatases in TOR signaling in yeast. , 2004, Current topics in microbiology and immunology.
[163] R. Pearson,et al. mTOR-Dependent Regulation of Ribosomal Gene Transcription Requires S6K1 and Is Mediated by Phosphorylation of the Carboxy-Terminal Activation Domain of the Nucleolar Transcription Factor UBF† , 2003, Molecular and Cellular Biology.
[164] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[165] J. Arthur,et al. In vivo role of the PIF‐binding docking site of PDK1 defined by knock‐in mutation , 2003, The EMBO journal.
[166] J. Blenis,et al. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.
[167] K. Inoki,et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.
[168] D. Kupferwasser,et al. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1. , 2003, The Biochemical journal.
[169] J. Blenis,et al. TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function , 2003, Current Biology.
[170] J. Avruch,et al. The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif* , 2003, The Journal of Biological Chemistry.
[171] W. Manning,et al. Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice , 2003, Circulation.
[172] Rainer Cramer,et al. Protein Kinase C Phosphorylates Ribosomal Protein S6 Kinase βII and Regulates Its Subcellular Localization , 2003, Molecular and Cellular Biology.
[173] J. Blenis,et al. Characterization of Phosphatidylinositol 3-Kinase-dependent Phosphorylation of the Hydrophobic Motif Site Thr389 in p70 S6 Kinase 1* , 2002, The Journal of Biological Chemistry.
[174] Maria Deak,et al. A phosphoserine/threonine‐binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation , 2002, The EMBO journal.
[175] J. Crespo,et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. , 2002, Molecular cell.
[176] T. Golub,et al. The Immunosuppressant Rapamycin Mimics a Starvation-Like Signal Distinct from Amino Acid and Glucose Deprivation , 2002, Molecular and Cellular Biology.
[177] J. Avruch,et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.
[178] D. Sabatini,et al. mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.
[179] J. Blenis,et al. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.
[180] J. Blenis,et al. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.
[181] P. Brennan,et al. Regulation of an Activated S6 Kinase 1 Variant Reveals a Novel Mammalian Target of Rapamycin Phosphorylation Site* , 2002, The Journal of Biological Chemistry.
[182] J. Blenis,et al. Identification of a Conserved Motif Required for mTOR Signaling , 2002, Current Biology.
[183] Hua Tang,et al. Amino Acid-Induced Translation of TOP mRNAs Is Fully Dependent on Phosphatidylinositol 3-Kinase-Mediated Signaling, Is Partially Inhibited by Rapamycin, and Is Independent of S6K1 and rpS6 Phosphorylation , 2001, Molecular and Cellular Biology.
[184] Jie Chen,et al. Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling , 2001, Science.
[185] C. Proud,et al. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.
[186] M. Mann,et al. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[187] L. Mayo,et al. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[188] J. Blenis,et al. Regulation of Ribosomal S6 Kinase 2 by Effectors of the Phosphoinositide 3-Kinase Pathway* , 2001, The Journal of Biological Chemistry.
[189] J. Blenis,et al. Ribosomal S6 Kinase 2 Inhibition by a Potent C-terminal Repressor Domain Is Relieved by Mitogen-activated Protein-Extracellular Signal-regulated Kinase Kinase-regulated Phosphorylation* , 2001, The Journal of Biological Chemistry.
[190] R. Burcelin,et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.
[191] J. Chen,et al. Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[192] W. J. Wu,et al. Cdc42 Stimulates RNA Splicing via the S6 Kinase and a Novel S6 Kinase Target, the Nuclear Cap-binding Complex* , 2000, The Journal of Biological Chemistry.
[193] J. Kononen,et al. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. , 2000, Cancer research.
[194] P. Cohen,et al. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells , 2000, Current Biology.
[195] Kenta Hara,et al. Immunopurified Mammalian Target of Rapamycin Phosphorylates and Activates p70 S6 Kinase α in Vitro * , 1999, The Journal of Biological Chemistry.
[196] E. Hafen,et al. Drosophila S6 kinase: a regulator of cell size. , 1999, Science.
[197] H. Koh,et al. Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); A novel nuclear target of Akt , 1999, Oncogene.
[198] J. Blenis,et al. Characterization of S6K2, a novel kinase homologous to S6K1 , 1999, Oncogene.
[199] S. Schreiber,et al. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[200] J. Blenis,et al. p70 S6 Kinase Is Regulated by Protein Kinase Cζ and Participates in a Phosphoinositide 3-Kinase-Regulated Signalling Complex , 1999, Molecular and Cellular Biology.
[201] A. Marotta,et al. Identification of Kinase-Phosphatase Signaling Modules Composed of p70 S6 Kinase-Protein Phosphatase 2A (PP2A) and p21-activated Kinase-PP2A* , 1999, The Journal of Biological Chemistry.
[202] K. Miyazono,et al. Cloning and Characterization of p70S6KβDefines a Novel Family of p70 S6 Kinases , 1998 .
[203] Stefano Fumagalli,et al. Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.
[204] I. Gout,et al. Molecular Cloning and Characterization of a Novel p70 S6 Kinase, p70 S6 Kinase β Containing a Proline-rich Region* , 1998, The Journal of Biological Chemistry.
[205] Joseph Avruch,et al. Regulation of the p70 S6 Kinase by Phosphorylation in Vivo , 1998, The Journal of Biological Chemistry.
[206] R. Pearson,et al. Phosphorylation Sites in the Autoinhibitory Domain Participate in p70s6k Activation Loop Phosphorylation* , 1998, The Journal of Biological Chemistry.
[207] S. Snyder,et al. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[208] M. Andjelkovic,et al. Phosphorylation and activation of p70s6k by PDK1. , 1998, Science.
[209] Dario R. Alessi,et al. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro , 1998, Current Biology.
[210] R. Pearson,et al. Dual requirement for a newly identified phosphorylation site in p70s6k , 1997, Molecular and cellular biology.
[211] Christine C. Hudson,et al. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.
[212] R. Pearson,et al. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.
[213] P. Cohen,et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.
[214] G. Thomas,et al. The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases , 1996, Molecular and cellular biology.
[215] J. Blenis,et al. The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1 , 1996, Cell.
[216] A. Gingras,et al. Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation. , 1996, The EMBO journal.
[217] R. Abraham,et al. Immunopharmacology of rapamycin. , 1996, Annual review of immunology.
[218] J. Blenis,et al. Structural and functional analysis of pp70S6k. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[219] W. Yeh,et al. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[220] R. Pearson,et al. The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. , 1995, The EMBO journal.
[221] R. Pearson,et al. Rapamycin, Wortmannin, and the Methylxanthine SQ20006 Inactivate p70s6k by Inducing Dephosphorylation of the Same Subset of Sites (*) , 1995, The Journal of Biological Chemistry.
[222] J. Avruch,et al. Multiple independent inputs are required for activation of the p70 S6 kinase , 1995, Molecular and cellular biology.
[223] P. Sassone-Corsi,et al. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression , 1994, Cell.
[224] G. Thomas,et al. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[225] M. Siegmann,et al. The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites. , 1993, The Journal of biological chemistry.
[226] J. Avruch,et al. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.
[227] S. Ferrari,et al. Activation of p70s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr-Pro motifs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[228] G. Crabtree,et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.
[229] G. Crabtree,et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.
[230] J. Avruch,et al. An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. , 1992, The Journal of biological chemistry.
[231] J. Woodgett,et al. Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini , 1991, Molecular and cellular biology.
[232] J. Avruch,et al. Insulin-activated protein kinases phosphorylate a pseudosubstrate synthetic peptide inhibitor of the p70 S6 kinase. , 1991, The Journal of biological chemistry.
[233] J. Heitman,et al. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast , 1991, Science.
[234] J. Avruch,et al. Molecular structure of a major insulin/mitogen-activated 70-kDa S6 protein kinase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[235] M. Siegmann,et al. Cloning of the mitogen-activated S6 kinase from rat liver reveals an enzyme of the second messenger subfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[236] J. Blenis,et al. A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[237] R. Martel,et al. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. , 1977, Canadian journal of physiology and pharmacology.
[238] S. Sehgal,et al. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.:II. FERMENTATION, ISOLATION AND CHARACTERIZATION , 1975 .
[239] S. Sehgal,et al. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. , 1975, The Journal of antibiotics.